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Abstract
Objectives The purpose was to determine prevalence of
enchondromas and atypical cartilaginous tumour/
chondrosarcoma grade 1 (ACT/CS1) of the knee on MRI in
a large cohort study, namely the Netherlands Epidemiology of
Obesity (NEO) study.
Methods Participants aged 45 to 65 years were prospectively
included, oversampling overweight and obese persons.Within
a subgroup of participants, MRI of the right knee was per-
formed and screened for incidental cartilaginous tumours, as
defined by their characteristic location and appearance.
Results Forty-nine cartilaginous tumours were observed in 44
out of 1285 participants (estimated population prevalence
2.8 %, 95 % CI 2.0–4.0 %). Mean largest tumour diameter
was 12 mm (range 2–31 mm). Eight participants with a tu-
mour larger than 20 mm or a tumour with aggressive features
were referred to rule out low-grade chondrosarcoma. One was
lost to follow-up, three had histologically proven ACT/CS1
and four had dynamic contrast MRI findings consistent with
benign enchondroma.
Conclusions Incidental cartilaginous tumours were relatively
common on knee MRI and may be regarded as a normal
concurrent finding. However, more tumours than expected
were ACT/CS1. Because further examination was performed
only when suspicion of chondrosarcoma was high, the actual
prevalence might be even higher.
Key Points
• Incidental cartilaginous tumours are relatively common on
knee MRI.
• Most incidental cartilaginous tumours are small and lack
suspicious features.
• Small cartilaginous tumours without suspicious findings
may be a normal concurrent finding.
• Large tumours and/or those with suspicious findings should
be further investigated.
• Atypical cartilaginous tumour/chondrosarcoma grade 1 was
found more often than expected.
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Introduction
Enchondromas are benign cartilaginous tumours located with-
in the bone marrow. They are one of the most common osse-
ous neoplasms and are often found incidentally on radio-
graphs, computed tomography or magnetic resonance imag-
ing (MRI), especially of the knee [1]. It is important to distin-
guish them from atypical cart i laginous tumour/
chondrosarcoma grade 1 (ACT/CS1), which requires surgical
treatment. Differentiating them is difficult when they are lo-
cated in the long tubular bones [2].
Enchondromas are composed of lobules of hyaline carti-
lage, consisting of benign chondrocytes with or without sur-
rounding reactive bone formation [3]. Mutations of isocitrate
dehydrogenase 1 (IDH1) and IDH2 have been identified in
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enchondromas and chondrosarcomas, in patients with both
solitary and multiple neoplasms [4, 5]. Enchondromas are
typically asymptomatic, except in the case of very large le-
sions which may be painful or may fracture.
During routine screening of knee MRIs for incidental
findings, performed in a cohort study to investigate osteo-
arthritis, cartilaginous tumours were frequently observed.
Because enchondromas are clinically silent, reliable data
concerning their incidence and prevalence is scarce [1,
6]. The purpose of this study was to describe the preva-
lence, characteristics and location of incidental cartilagi-
nous tumours on knee MRI in a population-based cohort
study.
Materials and methods
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a
population-based prospective cohort study that includes 6673
individuals aged 45 to 65 years, with an oversampling of
individuals deemed overweight or obese. This cohort was de-
signed to prospectively study pathways that lead to disease in
such individuals. Detailed information about the study design
and data collection has been described elsewhere [7]. Men and
women aged between 45 and 65 years with a self-reported
body mass index (BMI) of 27 kg/m2 or higher and living in
the greater area of Leiden (in the west of the Netherlands)
were eligible to participate in the NEO study. In addition, all
inhabitants aged between 45 and 65 years from one nearby
municipality (Leiderdorp) were invited, irrespective of their
BMI. At baseline, participants completed a questionnaire
about demographic and clinical data and underwent an exten-
sive physical examination. In random subsamples of partici-
pants without contraindications, MRI of abdominal fat, pulse
wave velocity of the aorta, heart, brain or right knee was
performed. All MR images were screened for incidental find-
ings. Incidental abnormal results with potential health conse-
quences if left undiagnosed were disclosed to the participants
and their general practitioners, accompanied by advice for
further work-up.
The present study is a cross-sectional analysis of the base-
linemeasurements of the 1285 participants with anMRI of the
knee. The local medical ethics committee approved the study
and all participants gave written informed consent.
All participants were asked whether they had pain in the
right knee during most days of the previous month. Weight
and height were measured without shoes and with precision of
0.1 cm/kg and 1 kg was subtracted from the weight for cloth-
ing. BMI was calculated by dividing the weight in kilograms
by the height in metres squared.
MRI of the right knee
MRI studies were performed on a 1.5-T MRI system (Philips,
Best, the Netherlands) with a dedicated 8-channel knee coil.
The following parameters were identical for the TSE images:
echo train length 6, a 150–160 mm field of view and a 304×
512 matrix. Sequences acquired were (1) coronal proton den-
sity (PD) (repetition time (TR)/echo time (TE) 2335/35 ms;
3 mm slice thickness; 0.6 mm interslice gap); (2) coronal fat
suppressed PD TSE images (TR/TE 2334/35 ms; 3 mm slice
thickness; 0.6 mm interslice gap); (3) sagittal PD TSE images
(TR/TE 2338/35; 3.5 mm slice thickness; 0.7 mm interslice
gap); (4) sagittal frequency selective fat-suppressed T1-
weighted 3D gradient echo (GE) sequence (TR/TE 11/5.5;
25° flip angle; 150 mm field of view, 272×512 matrix,
2 mm slice thickness with a 1-mm overlap between images;
no gap); (5) axial fat suppressed PD (TSE) images (TR/TE
3225/15; 4 mm slice thickness; 0.8 mm interslice gap). Total
acquisition time was 30 min.
Lesion analysis
A research fellow trained in reading knee MRIs initially
screened all MRIs for the presence of any abnormality. All
of these were subsequently discussed with a musculoskeletal
radiologist. All lesions possibly fulfilling the criteria set for
cartilaginous tumour were assessed by two musculoskeletal
radiologists with more than 10 years experience in consensus
to determine lesion characteristics. Cartilaginous tumours
were defined as a smooth or lobulated lesion of geographic
bone destruction pattern within the bone marrow with low
signal on PD-weighted images and high signal on PD fat-
suppressed images. Subchondral lesions were excluded, be-
cause theymay represent subchondral cysts, intraosseous gan-
glia or subchondral oedema. We included and recorded char-
acteristics of all other osseous lesions that could be bone tu-
mours or tumour-like lesions of bone. For all included lesions
we recorded size in three dimensions, shape (lobulated, oval
or round), bone destruction pattern i.e. geographic with well-
defined or partially ill-defined margins, permeative or moth-
eaten. The location was determined to be either central or
eccentric and located in the epiphysis, epi-metaphysis,
metaphysis and/or diaphysis. The distance of the tumour to
the growth plate was classified as a lesion being in contact
with the physis, within 2 cm, or further away from the physis.
The relationship with the cortex in eccentric lesions was de-
termined (contact or no contact). The presence or absence of
superficial (one-third of depth) or deep (at least two-thirds of
depth) scalloping (i.e. focal resorption of the inner margin of
cortical bone), cortical bone destruction and periosteal reac-
tion was recorded. Signal intensity was scored as low, inter-
mediate or high compared to muscle on both PD and fat-
suppressed PD-weighted images. The presence of speckled
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low signal intensity on both the PD and gradient-echo se-
quence in the lesion was scored as calcifications. Presence or
absence of bone marrow oedema in direct contact or within
2 cm from the lesion was noted. Participants with lesions that
were larger than 20 mm or that had aggressive characteristics
(i.e. cortical bone destruction, periosteal reaction, deep endos-
teal scalloping, (partial) ill definition of margin) were
contacted and referred for dynamic contrast MRI to differen-
tiate enchondroma from ACT/CS1. Large lesion size is a
known risk factor for chondrosarcoma but no specific limit
is known which optimally differentiates between
enchondroma and ACT/CS1. We chose a conservative cut-
off of 20 mm as a trade-off between increased sensitivity
and avoiding unnecessary extra diagnostic procedures.
Dynamic contrast MR
Data acquisition was performed during intravenous injection
of Gd-DTPA (dose 2 mg/kg body weight, power injector with
2 ml/s) with a temporal resolution of 3 s. We recorded on
electronic subtraction images the time interval between arteri-
al enhancement and the start of lesion enhancement. Lesions
enhancing within 10 s were classified as early enhancement
consistent with ACT/CS1, while lesions that did not enhance,
or enhanced after more than 10 s were classified as
enchondroma [8]. In addition we retrieved follow-up radio-
graphs, and MRI studies when these had been performed.
Changes of described parameters between initial and follow-
up MRI studies and radiographs were recorded.
Histological diagnosis
When the aforementioned features on radiographs or MRI
suggesting the presence of ACT/CS1 were present, material
was obtained (curettage or resection) to allow a histological
diagnosis to be made. Previously described histological
criteria were used [9]. All involved pathologists had extensive
experience with bone tumour pathology owing to the
hospital’s function as a tertiary referral centre for orthopaedic
oncology.
Statistical analyses
Characteristics of the lesions were expressed as number of the
total number of lesions. In order to correctly estimate the pop-
ulation prevalence of cartilaginous tumours and represent as-
sociations in the general population, all other results were
based on weighted analyses adjusting for the oversampling
of persons with a BMI of 27 kg/m2 or higher in the NEO study
[10]. This was done by weighing individuals towards the BMI
distribution of participants from the Leiderdorp municipality
[11], whose BMI distribution was similar to the BMI distribu-
tion of the general Dutch population [12]. Weighted baseline
characteristics of the study populationwere expressed asmean
(SD) or as percentage. Participants were categorized into four
groups based on their BMI (BMI<25, 25≤BMI<30, 30≤
BMI<40 and BMI≥40 kg/m2). Logistic regression analysis
was used to examine the associations of BMI (both as a con-
tinuous variable and as a categorical variable using BMI<
25 kg/m2 as the reference group), age (continuous), sex, and
knee pain with the presence of cartilaginous tumours.
Results
Between September 2008 and October 2012, 6673 persons
aged 45 to 65 years were included in the NEO study, of whom
1285 underwent MRI of the right knee. Weighted mean (SD)
age was 56 (6) years, 45%were men and mean BMI was 27.1
(4.7) kg/m2. After screening of these 1285MRIs, 49 lesions in
44 participants were observed and classified as cartilaginous
tumours (estimated population prevalence 2.8 %, 95 % CI
2.0–4.0 %). Four participants had more than one lesion: three
participants had two and one participant had three lesions.
Using logistic regression analysis, we did not find any associ-
ation between BMI, age or sex and the presence of
Fig. 1 Small enchondroma in the
distal femur located centrally in
the metaphysis and with a typical
lobulated appearance: a PD-
weighted coronal section, b PD-
weighted coronal section with fat
saturation. No further imaging
was obtained
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cartilaginous tumours (data not shown). An example of a typ-
ical enchondroma is shown in Fig. 1. We did not encounter
any non-cartilaginous bone tumours.
Lesion characteristics
Mean lesion size was 12 (range 2 – 31) mm in the longest
axis. Of the 49 tumours, seven tumours were larger than
20 mm. Thirty-six lesions were lobulated, 12 had a
smooth round shape and one was oval-shaped. All had a
geographic bone destruction pattern and were well
defined. Thirty-eight were located in the distal femur,
eight in the proximal tibia, two in the proximal fibula
and one in the patella. Nineteen tumours were located
centrally in the medullary canal and 30 eccentrically
(but still within the medullary canal). Of all tumours, 27
were located in the metaphysis, 10 in the epi-metaphysis
(crossing the growth plate), ten in the diaphysis and one
in the epiphysis (not applicable for the lesion in the pa-
tella). Twenty-nine were in contact with the growth plate,
nine crossed the growth plate and ten were located more
than 2 cm from the growth plate (not applicable for the
Fig. 2 Large cartilaginous
tumour centrally located in the
distal femur, referred for follow-
up: a axial and b sagittal T1-
weighted images, c axial T2-
weighted image, d axial and e
sagittal T1-weighted images after
gadolinium administration with
fat suppression. The time–signal
intensity curve of the dynamic
MRI (e) showed slow
enhancement consistent with
enchondroma (pink artery, orange
tumour, and blue bone marrow as
reference tissue). The vertical axis
represents relative signal intensity
and the horizontal axis represents
time in seconds
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lesion in the patella). In 11 lesions there was contact with
the cortex and in one lesion there was focal destruction of
the cortex. In three cases there was minimal and in one
case obvious deep endosteal scalloping. Periosteal reac-
tion was not seen. Signal intensity was intermediate on
PD images and heterogeneously high on PD-SPIR images
for all lesions. The presence of calcifications within the
lesion was observed in 11 lesions. None of the lesions had
surrounding oedema.
Eight lesions in eight participants displayed at least
one of the predefined aggressive criteria and were re-
ferred for follow-up. Seven had a tumour larger than
20 mm (range 22–31 mm), including one with deep end-
osteal scalloping. One participant had a smaller tumour
but with focal cortical destruction. In six of the seven
participants referred because of tumour size, dynamic
contrast MRI was performed, while one patient was sub-
sequently lost to follow-up. In four participants there
was slow lesional enhancement (i.e. the interval between
arterial enhancement and lesion enhancement was great-
er than 10 s) after intravenous Gd-chelate administration
consistent with benign enchondroma (Fig. 2); no subse-
quent follow-up was performed in these patients. In the
fifth patient with a lesion of 22 mm, and in the sixth
patient with a larger lesion with deep endosteal
scalloping, dynamic contrast MRI demonstrated a fast
enhancement pat tern consis tent with ACT/CS1.
Curettage and en bloc resection of the tumour were per-
formed respectively, and pathology confirmed the diag-
nosis of ACT/CS1 (Fig. 3). The patient with the smaller
lesion but with focal cortical destruction had radiograph-
ic follow-up and underwent curettage 2 years later,
showing an ACT/CS1 at histology. The three ACT/
CS1s that were found correspond to an estimated popu-
lation prevalence of 0.4 % (95 % CI 0.2–0.8 %).
Association of BMI, age, sex and knee pain with presence
of cartilaginous tumours
Estimated population prevalence of cartilaginous tumours
in BMI strata are shown in Table 1. Univariate logistic
regression analysis did not reveal associations between
BMI, age, sex and the presence of cartilaginous tumour,
but it was suggestive of an inverse association with knee
pain (Table 2). Multivariate logistic regression using the
same variables showed an inverse association between the
presence of knee pain and the presence of cartilaginous
tumour but no association with BMI (as continuous vari-
able), age or sex. Compared with having a BMI<25 kg/
m2, the odds ratio (OR, 95 % confidence interval) of the
presence of cartilaginous tumour associated with a BMI of
25–30 kg/m2 was 1.79 (0.38, 8.51), with a BMI of 30–
40 kg/m2 it was 1.69 (0.38, 7.47), and with a BMI>40 kg/
m2 it was 3.74 (0.64, 21.87).
Fig. 3 Large cartilaginous tumour centrally located in the distal femur,
referred for follow-up: a axial and b sagittal T1-weighted images, c axial
T2-weighted image, d axial and e sagittal T1-weighted images after
gadolinium administration with fat suppression. The time–signal
intensity curve of the dynamic MRI (e) showed fast enhancement
(<10 s), interpreted as most likely ACT/CS1, although chondrosarcoma
grade 2 could not be excluded due to extensive presence of mucoid (pink
artery, orange tumour, and blue bone marrow as reference tissue). The
vertical axis represents relative signal intensity and the horizontal axis
represents time in seconds. Curettage was performed and histology (f)
confirmed the presence of cartilaginous tumour with increased cellularity
and occasional binucleated cells as well as focal mucomyxoid matrix
changes (left lower area), diagnosed as atypical cartilaginous tumour/
chondrosarcoma grade 1
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Discussion
In a cohort study including knee MRI to investigate osteoar-
thritis, we observed incidental lesions that we classified as
cartilaginous tumours on the basis of predefined imaging
criteria in 2.8 % of individuals between 45 and 65 years of
age. These cartilaginous tumours were all smaller than 32mm,
typically smaller than 20 mm and were located near the fem-
oral or sometimes tibial metaphysis.
The prevalence of ACT/CS1 in our population was low
(0.4 %), but we found an ACT/CS1 in three out of seven
participants whom we classified, on the basis of predefined
criteria, as high risk of carrying an ACT/CS1 and had a com-
plete data set. These ACT/CS1s were present in two partici-
pants with tumours exhibiting aggressive features (deep end-
osteal scalloping or cortical bone destruction) and one partic-
ipant with a tumour of 22 mm and were either resected or
removed by curettage. In four other lesions with a diameter
of greater than 20 mm the criteria of dynamic MRI were con-
sistent with an indolent benign enchondroma [8].
Because cartilaginous tumours are typically clinically silent
reliable data concerning their epidemiology are scarce. Similar
to our study, Walden et al. reported an enchondroma preva-
lence of 2.9 % on clinical knee MRI [13]. In skeletally
immature children undergoing knee MRI for a variety of
indications, enchondroma prevalence was also 2.9 % [14].
In neither of these two studies was further follow-up per-
formed. Our study confirms these results with a similar prev-
alence of cartilaginous tumours of 2.8 %. However, we also
showed that ACT/CS1s are relatively common among larger
tumours and those with suspicious features. In an autopsy case
series, a prevalence of enchondromas of only 0.2 % was ob-
served, likely reflecting the higher sensitivity of MRI for de-
tecting small lesions [15]. Other asymptomatic osseous tu-
mours were not encountered in our cohort, which means that
the prevalence of these is, in our age group, less than that of
cartilaginous tumours and below 0.1 %. Our data did not re-
veal a clear association with age, sex or BMI as a continuous
variable, and an inverse association with knee pain. The latter
finding may merely reflect that participants with cartilaginous
tumours do not suffer from knee pain. There was a clear trend
towards a higher prevalence in higher BMI groups; however,
the number of detected cartilaginous tumours was probably
too low to reach a significant association in the logistic regres-
sion analysis.
The high sensitivity ofMRI in detecting small cartilaginous
tumours on MRI performed for other purposes can pose a
dilemma to the clinician. The main differential diagnosis of
enchondroma is ACT/CS1. In high-grade chondrosarcoma,
clinical, radiographic and pathological findings generally are
apparent and treatment consists of surgical resection with a
wide margin. However, differentiating ACT/CS1 from
enchondroma is challenging, especially in the case of inciden-
tal asymptomatic lesions found on imaging. Asymptomatic
enchondromas do not need treatment, while ACT/CS1s are
treated surgically [16].
Suggestions on how to address this dilemma have been
made (Table 3). Radiographic signs are not useful in fur-
ther classifying these small enchondromas. In a previous
radiograph-based case series, location in the axial skeleton
and size greater than 5 cm were the most reliable predic-
tors for low-grade chondrosarcoma, while clinical symp-
toms and morphologic radiographic features did not have
added value [17]. Radiographic signs indicating potential
Table 1 Participant
characteristics and prevalence of











Age (years) 56 (6) 56 (6) 55 (6) 53 (6)
Sex (% women) 63 46 60 84
BMI (kg/m2) 22.6 (1.5) 27.4 (1.3) 33.3 (2.7) 42.9 (2.4)
Cartilaginous tumour prevalence (%) 1.9 3.2 3.1 7.1
Knee pain (% yes) 14 17 23 27
Results are based on weighted analysis of the study population (n=1285). Values are presented as mean (SD) or
percentages
Table 2 Univariate and multivariate analysis for risk factors of
presence of cartilaginous tumours
Variables Univariate analysis Multivariate analysis
OR (95 % CI) P OR (95 % CI) P
BMI (kg/m2) 1.05 (0.97–1.14) 0.202 1.06 (0.98–1.14) 0.168
Age (year) 0.97 (0.91–1.04) 0.400 0.98 (0.91–1.05) 0.482
Sex (woman) 1.20 (0.45–3.14) 0.717 1.23 (0.47–3.23) 0.673
Knee pain (yes) 0.44 (0.18–1.10) 0.080 0.40 (0.18–0.93) 0.034
Results are based on weighted analysis of the study population (n=1285)
CI confidence interval, OR odds ratio
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chondrosarcoma have been described by Parlier–Cuau
et al.; however, no radiographs were made in our cohort
[18]. Only bone scintigraphy (intense uptake on delayed
images without presence of fracture) and dynamic Gd-
chelate-enhanced MRI (start of enhancement within 10 s
after arterial enhancement) have been reported to add in-
formation on differentiating enchondroma from ACT/CS1
[19–21]. We observed MRI signs suggest ive of
chondrosarcoma such as deep endosteal scalloping, corti-
cal destruction and soft-tissue extension in two out of
three participants who indeed turned out to have ACT/
CS1 [21]. Nevertheless, even with dynamic contrast-
enhanced MRI, differentiating cartilaginous tumours re-
mains challenging with false-positive findings unavoid-
able [22].
Chondrosarcoma incidence has been estimated at
0.0005 % per year and prevalence at 0.001–0.009 %, with
only 7 % of those located around the knee [23–25]. In our
study we observed an unexpectedly high estimated popu-
lation prevalence of ACT/CS1 of 0.4 %. As no further
examinations or follow-up were performed when tumours
were small and lacked suspicious features, the actual
prevalence of ACT/CS1 may be even higher. Thus knee
MRI performed in participants should be carefully
reviewed for the presence of cartilaginous tumours. Only
small lesions lacking suspicious features may be regarded
as a normal concurrent finding on MRI. In patients with
any of the described suspicious features, the chance of
having an ATC/CS1 is quite high (three out of seven in
our population).
Limitations
The present study was conducted in a cohort study of volun-
teers. Compared to the general population, participants may
bemore conscious about their health. As a consequence, some
may have had a healthier lifestyle, while others may have had
more health complaints and participated because of the diag-
nostic examinations performed as part of the study.
Furthermore, a large proportion of participants were over-
weight or obese. To estimate the population prevalence we
weighted the analyses towards the BMI distribution of a pop-
ulation comparable to the general Dutch population.
Radiographs were not available for the study group, making
it impossible to determine the discrepancy between preva-
lence on radiographs andMRI. However, because the estimat-
ed population prevalence in our study was similar to that in
earlier studies, we are confident that our results are robust.
Because of the benign nature of enchondromas, there are
no histopathological studies confirming the origin of the oth-
erwise unsuspicious lesions and they are classified as
enchondromas solely on imaging findings. As we did not
routinely do resections and do not yet have 10-year follow-
up, the proof of excluding ACT/CS1 in the three unsuspicious
larger lesions was incomplete.
Conclusion
The estimated population prevalence of incidental asymptom-
atic cartilaginous tumours around the knee was 2.8 %.
Typically the lesions were less than 20 mm in size, were lo-
cated within 2 cm of the growth plate and did not cause cor-
tical abnormalities. The prevalence of ACT/CS1 may be
higher than previously thought (0.4 %). Given the high prev-
alence of enchondromas, as a practical rule we do not advo-
cate further imaging examination or follow-up of accidentally
found cartilaginous tumours in patients up to 65 years when
the tumours are small (at most 20 mm) and suspicious features
such as deep endosteal scalloping or cortical destruction are
absent. However, when any of these suspicious features are
present, or when the lesion is larger than 20 mm in diameter,
further analysis is indicated.
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Early (<10 s) enhancement on dynamic contrast MRI
Intense uptake on bone scintigraphy
FDG-PET high uptake*
Imaging features reported in the literature making a diagnosis of
chondrosarcoma more likely. List synthesized from refs. [17–21]
*Features suggestive of high-grade (grade 1 and 2) chondrosarcoma
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